We identified 28 gene sets and 95 core genes exacerbated in the C2 class, and two transcription factors (E2F1 and FOXM1) that are known to affect prognosis and response to therapy in different cancer types, and might be responsible for most of the differences between the two classes. This evidence concerns the gene FOXM1 and cancer.